Mounjaro before and after 1 week: what actually changes first

Step 1 — The injection itself and the hours that follow

You take your first 2.5 mg dose on day one. Mounjaro is a once-weekly subcutaneous injection via a pre-filled KwikPen, administered into the abdomen, thigh or upper arm. Most people feel nothing unusual in the first hour or two. By the evening, or sometimes the following morning, two things often become noticeable: food feels less appealing, and smaller portions feel satisfying. That's the dual GIP and GLP-1 receptor mechanism beginning to work, it slows gastric emptying and signals fullness to the brain. The NHS patient information for tirzepatide confirms appetite reduction is expected early in treatment.

This is also when any gastrointestinal side effects tend to begin, if they're going to. Nausea is the most commonly reported. It's usually mild, tied to meals, and settles within days for most people. Eating smaller portions, avoiding fatty or rich foods, and staying hydrated all help. A quick habit worth building from day one: weigh yourself at the same time each morning, before eating or drinking, and write it down. A week's worth of daily readings gives a much more honest picture than a single Friday weigh-in.

For detail on how the medicine works from the first dose onward, the full timeline of how long Mounjaro takes to work covers the pharmacology in more depth.

Step 2, Days two to four: the appetite shift becomes real

By day two or three the appetite effect is usually undeniable. People describe thinking less about food between meals, feeling full after eating roughly half of what they'd normally eat, and finding that cravings (particularly for high-calorie snacks) are quieter. This is not psychological; it's the medicine changing hormonal signalling around hunger and satiety.

Weight change at this stage is typically small, often within normal daily fluctuation. Fluid shifts, digestive slowdown and dietary changes can all move the number on the scales independently of actual fat loss. A drop of one to two kilograms in week one is possible but not universal, and some people see no change at all while still experiencing significant appetite suppression. Neither outcome is a signal that the medicine is or isn't working, the 2.5 mg dose exists to ease your system in, not to drive the largest possible loss immediately.

If you are interested in what the trajectory looks like across a longer stretch, the week-by-week Mounjaro weight-loss breakdown maps the pattern from weeks one through to the later titration doses.

Step 3, Days five to seven: assessing your first week honestly

By the end of the first week most people have a clearer sense of how their body is responding. The questions worth asking yourself are practical ones. Are you eating less without trying to? Is nausea manageable, bothersome but not stopping you from functioning? Are you staying hydrated? These matter more than the number on the scales right now.

Clinical trial data from the SURMOUNT-1 study, published in the New England Journal of Medicine, shows that participants who went on to lose around 20–21% of their body weight at 72 weeks did so gradually, with the most significant reductions accumulating through the titration phase, not in week one. The first injection is the beginning of a process, not a result in itself.

For context on what the data shows across a month of treatment, if you want to see what Mounjaro before and after results look like at one month and through eight weeks, that gives a more representative picture of what people experience once they reach therapeutic doses. You can also browse real 8 week weight loss before and after Mounjaro accounts, which show how results tend to build as people move through the titration doses. The Mounjaro before-and-after overview puts individual variation in perspective too.

What the first week does not tell you

One week is genuinely too early to judge effectiveness in terms of weight. The 2.5 mg starting dose is not the maintenance dose; most people titrate upward through 5 mg, 7.5 mg and beyond over the following months, guided by their prescriber. The clinical work (and the clinical results) happen across that full titration journey.

What week one does tell you is how your body is tolerating the medicine. If side effects are severe, persistent beyond a couple of weeks, or include anything more concerning than digestive discomfort, that's a conversation to have with your prescriber promptly. The NHS tirzepatide medicines page lists side effects and gives clear guidance on which symptoms need urgent medical attention.

Mounjaro is a prescription-only medicine. The details of titration, what to do if you miss a dose, and how long to stay at each strength are set out in your Patient Information Leaflet and, importantly, with your prescriber. Decisions about your treatment always sit with the clinician, not a guide like this one. If you're weighing up your options, speaking to our prescribers is a practical next step, the consultation is free and reviewed the same day by a GPhC-registered prescriber. There's also broader context on the Mounjaro treatment overview if you want to understand the full picture before starting.